Catalyst Wire Dossier Catalyst Wire Dossier

ASLAN003

· ASLAN Pharmaceuticals
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ASLAN003, covering 2016-11-02 to 2021-07-02. Get the full timeline:

Most recent: Clinical Trial Update: A Dose Optimisation Study of ASLAN003 in Acute Myeloid Leukemia [Phase 2]

See pricing